LHON Syndrome Treatment with Idebenone — idebenone.org
Leber’s Hereditary Optic Neuropathy (LHON) is a rare mitochondrial disorder that leads to rapid vision loss due to dysfunctional energy production in retinal cells. Idebenone, a short-chain benzoquinone, is currently the only disease-specific therapy shown to benefit LHON patients by bypassing mitochondrial complex I dysfunction and improving cellular energy supply to retinal ganglion cells. Read more: https://idebenone.org/
Aimer
Commentaire
Partagez
